Obtaining hyperimmune anti-coli (anti-Escherichia) human plasma. 1977

S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili

Anticoli (anti-Escherichia) plasma has been obtained from donors immunized with viable Escherichia oral vaccines, prepared from Str-d mutants of E. coli. Anticoli plasma has an therapeutic effect against diseases of Escherichia etiology.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
January 1969, Problemy gematologii i perelivaniia krovi,
S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
August 2017, Clinical and vaccine immunology : CVI,
S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
October 2020, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
April 1987, Clinical and experimental immunology,
S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
April 1974, Problemy gematologii i perelivaniia krovi,
S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
January 2019, Human vaccines & immunotherapeutics,
S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
July 2019, The Journal of infectious diseases,
S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
May 1956, Journal of bacteriology,
S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
January 1977, Laboratornoe delo,
S V Skurkovich, and V G Likhoded, and I V Golubeva, and M A Krokhina, and N V Demidova, and R M Temper, and N A Arkhipova, and N I Andronova, and I J Moshiashvili
January 1987, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
Copied contents to your clipboard!